Cardiol: Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
Study at a Glance
Estimated Time Commitment
60 Days, inpatient procedures on Day 1, 3, 5, 7; outpatient visits on Day 14, 21 and 28Eligibility
Adults Hospitalized for COVID but not in ICU.
Diagnosis Required
COVID PneumoniaDiseases Being Studied
COVIDClinical Trials.gov identifier NCT04615949
Meet Your Clinical Research Team
Contact us
Principal Investigator: Jan Patterson, M.D., M.S.Due to requirement for hospitalization at University Hospital, we will not be openly recruiting for the study.